1. Home
  2. SSBI vs PMN Comparison

SSBI vs PMN Comparison

Compare SSBI & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Summit State Bank

SSBI

Summit State Bank

HOLD

Current Price

$12.06

Market Cap

82.6M

Sector

Finance

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

BUY

Current Price

$8.24

Market Cap

84.1M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
SSBI
PMN
Founded
1982
2004
Country
United States
Canada
Employees
103
N/A
Industry
Major Banks
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.6M
84.1M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
SSBI
PMN
Price
$12.06
$8.24
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $42.90
AVG Volume (30 Days)
2.2K
★ 29.6K
Earning Date
11-02-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.23
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.35
$0.29
52 Week High
$14.00
$27.40

Technical Indicators

Market Signals
Indicator
SSBI
PMN
Relative Strength Index (RSI) 48.40 28.25
Support Level $12.22 $7.98
Resistance Level $13.75 $8.75
Average True Range (ATR) 0.41 0.90
MACD 0.02 -0.07
Stochastic Oscillator 46.53 3.69

Price Performance

Historical Comparison
SSBI
PMN

About SSBI Summit State Bank

Summit State Bank provides various banking products and services to individuals and businesses in Sonoma County, California. It offers personal and business checking, money market, sweep, savings, and demand accounts; time certificates of deposit; and specialized deposit accounts, such as professional, small business packaged, tiered, and retirement plan accounts. The company also provides loans, including commercial loans and leases; lines of credit; commercial real estate, small business administration, residential mortgage, and construction loans; home equity lines of credit; and term and equipment loans, as well as loans to agriculture-related businesses.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimers disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Compnies product candidates are PMN310, PMN267, and PMN442. Lead product candidate is PMN310, a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 is companies second lead product candidate targeting ALS.

Share on Social Networks: